Osteoprotegerin (OPG) and its ligands RANKL and TRAIL in falciparum, vivax and knowlesi malaria: correlations with disease severity, and B cell production of OPG
Arya Sheela Nair, John Woodford, View ORCID ProfileJessica Loughland, View ORCID ProfileDean Andrew, Kim Piera, Fiona Amante, Timothy William, View ORCID ProfileMatthew J Grigg, James S McCarthy, View ORCID ProfileNicholas M Anstey, View ORCID ProfileMichelle J Boyle, View ORCID ProfileBridget E Barber
doi: https://doi.org/10.1101/2024.07.22.24310838
Arya Sheela Nair
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
John Woodford
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
2Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, Bethesda, United States
Jessica Loughland
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
6Burnet Institute, Melbourne, Australia
Dean Andrew
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
Kim Piera
3Menzies School of Health Research, Darwin, Australia
Fiona Amante
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
Timothy William
4Subang Jaya Medical Centre, Selangor, Malaysia
Matthew J Grigg
3Menzies School of Health Research, Darwin, Australia
James S McCarthy
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
5Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
Nicholas M Anstey
3Menzies School of Health Research, Darwin, Australia
Michelle J Boyle
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
6Burnet Institute, Melbourne, Australia
Bridget E Barber
1QIMR Berghofer Medical Research Institute, Brisbane, Australia
3Menzies School of Health Research, Darwin, Australia
Data Availability statement
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Posted July 23, 2024.
Osteoprotegerin (OPG) and its ligands RANKL and TRAIL in falciparum, vivax and knowlesi malaria: correlations with disease severity, and B cell production of OPG
Arya Sheela Nair, John Woodford, Jessica Loughland, Dean Andrew, Kim Piera, Fiona Amante, Timothy William, Matthew J Grigg, James S McCarthy, Nicholas M Anstey, Michelle J Boyle, Bridget E Barber
medRxiv 2024.07.22.24310838; doi: https://doi.org/10.1101/2024.07.22.24310838
Osteoprotegerin (OPG) and its ligands RANKL and TRAIL in falciparum, vivax and knowlesi malaria: correlations with disease severity, and B cell production of OPG
Arya Sheela Nair, John Woodford, Jessica Loughland, Dean Andrew, Kim Piera, Fiona Amante, Timothy William, Matthew J Grigg, James S McCarthy, Nicholas M Anstey, Michelle J Boyle, Bridget E Barber
medRxiv 2024.07.22.24310838; doi: https://doi.org/10.1101/2024.07.22.24310838
Subject Area
Subject Areas
- Addiction Medicine (371)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2754)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12403)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4261)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2758)
- Health Policy (1019)
- Hematology (369)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (453)
- Neurology (4043)
- Nursing (216)
- Nutrition (599)
- Oncology (2128)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1149)
- Primary Care Research (470)
- Public and Global Health (6653)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)